Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Annals of Hematology|January 14, 2009
Aplastic anemia and concomitant autoimmune diseasesMagnus P Stalder, Alicia Rovó, Jörg Halter, et al.
Blood|August 1, 2007
Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantationAndré Tichelli, Christoph Bucher, Alicia Rovó, et al.
Bone Marrow Transplantation|October 13, 2022
Chronic gvhd dictionary-eurograft cost action initiative consensus reportAna Zelić Kerep, Atillio Olivieri, Helene Schoemans, et al.
Haematologica|October 12, 2010
Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantationRegula J Mueller, Georg Stussi, Gisella Puga Yung, et al.
British Journal of Haematology|December 10, 2009
Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAAAntonio Maria Risitano, Carmine Selleri, Bianca Serio, et al.
Blood Advances|August 27, 2021
Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantationStéphane Buhler, Helen Baldomero, Sylvie Ferrari-Lacraz, et al.
Bone Marrow Transplantation|November 14, 2021
Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantationEvgenii Shumilov, Inna Shakhanova, Johanna Flach, et al.
Swiss Medical Weekly|February 26, 2014
Forty years of haematopoietic stem cell transplantation: a review of the Basel experienceAlix O'Meara, Andreas Holbro, Sara Meyer, et al.
Orphanet Journal of Rare Diseases|September 18, 2020
Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH)Kimmo Weisshaar, Hannah Ewald, Jörg Halter, et al.
European Journal of Haematology|March 17, 2009
Infection prevention strategies in a stem cell transplant unit: impact of change of care in isolation practice and routine use of high dose intravenous immunoglobulins on infectious complications and transplant related mortalityNathan Cantoni, Maja Weisser, Andreas Buser, et al.
Pageof 9